Samantha DiGrande reports for AJMC that drug pricing was a reasonable subject for ASCO’s town hall as the Trump administration has made lowering the cost of medications a major objective. The administration has communicated a series of proposals looking to address the cost of drugs, such as the International Pricing Index (IPI), and the recently finalized rule around direct-to-consumer advertising for pharmaceutical companies.

Follow up on Ms. DiGrandre’s summary of the tensions concerning pricing raised during the town hall.

Source: AJMC

Pin It on Pinterest